STOCK TITAN

Bristol Myers Stock Price, News & Analysis

BMYMP OTC Link

Company Description

Bristol Myers (OTC Link: BMYMP) is a publicly traded company.

BMYMP stock has declined 33.3% over the past year. Shares last traded at $700.00.

On a trailing twelve-month basis, Bristol Myers reported revenue of $48.2B with net income of $7.1B and diluted earnings per share of $3.46. The company operates at a net profit margin of 14.6%.

This page provides a comprehensive overview of BMYMP stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
0.00%
0.00
Last updated:
-33.27%
Performance 1 year

Bristol Myers (BMYMP) stock last traded at $700.00. Over the past 12 months, the stock has lost 33.3%.

Latest News

No recent news available for BMYMP.

SEC Filings

Bristol Myers has filed 5 recent SEC filings, including 5 Form 4. The most recent filing was submitted on April 2, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BMYMP SEC filings →

Financial Highlights

Bristol Myers generated $48.2B in revenue over the trailing twelve months, retaining a 71.1% gross margin, and net income was $7.1B, reflecting a 14.6% net profit margin. Diluted earnings per share stood at $3.46. The company generated $14.2B in operating cash flow. With a current ratio of 1.26, the company maintains adequate short-term liquidity.

$48.2B
Revenue (TTM)
$7.1B
Net Income (TTM)
$14.2B
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Bristol Myers (BMYMP) currently stands at 49 shares, up 1000.0% from the previous reporting period, representing 1.4% of the float. Over the past 12 months, short interest has increased by 1533.3%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months

Days to cover for Bristol Myers (BMYMP) currently stands at 2.6 days, down 99.7% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 158% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.

Frequently Asked Questions

What is the current stock price of Bristol Myers (BMYMP)?

The current stock price of Bristol Myers (BMYMP) is $700 as of March 18, 2026.

What is the revenue (TTM) of Bristol Myers (BMYMP) stock?

The trailing twelve months (TTM) revenue of Bristol Myers (BMYMP) is $48.2B.

What is the net income of Bristol Myers (BMYMP)?

The trailing twelve months (TTM) net income of Bristol Myers (BMYMP) is $7.1B.

What is the earnings per share (EPS) of Bristol Myers (BMYMP)?

The diluted earnings per share (EPS) of Bristol Myers (BMYMP) is $3.46 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Bristol Myers (BMYMP)?

The operating cash flow of Bristol Myers (BMYMP) is $14.2B. Learn about cash flow.

What is the profit margin of Bristol Myers (BMYMP)?

The net profit margin of Bristol Myers (BMYMP) is 14.6%. Learn about profit margins.

What is the gross margin of Bristol Myers (BMYMP)?

The gross profit margin of Bristol Myers (BMYMP) is 71.1%. Learn about gross margins.

What is the current ratio of Bristol Myers (BMYMP)?

The current ratio of Bristol Myers (BMYMP) is 1.26, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of Bristol Myers (BMYMP)?

The gross profit of Bristol Myers (BMYMP) is $34.3B on a trailing twelve months (TTM) basis.